Cellective BioTherapy is dedicated to advancing novel platforms using cellular and monoclonal antibody-based approaches for the treatment of cancer, autoimmunity, and immunodeficiency. This biotechnology company is specifically focused on the research and development of B cell-based cellular therapies to address various aspects of immunomodulation, immunodeficiency, and autoimmunity. The scope of its research includes developing treatments for cancers, diabetes, asthma, congenital and acquired immunodeficiency, as well as vaccine development.

Disease Domain	Count

Immune System Diseases	2
Neoplasms	1
Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

Cell therapy	1
Immune cell therapy	1
Monoclonal antibody	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 27 Aug 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

Preclinical

Other

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Autologous B10 cell therapy(Cellective Biotherapy)	Severe Combined Immunodeficiency More	Preclinical
CBT-103	Neoplasms More	Preclinical
B10 cell expansion (Cellective BioTherapy Inc)	Graft vs Host Disease More	Discovery
CBT-107	Neoplasms More	Pending

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Hiro LS Researcher

The AI Search Engine Built to Accelerate Biopharma Decisions

Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.

Ask any biopharma research question→

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Discover Synapse Data Servers

Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis